PL435706A1 - Permetryna do zastosowania w leczeniu zewnętrznym infestacji Demodex spp. - Google Patents

Permetryna do zastosowania w leczeniu zewnętrznym infestacji Demodex spp.

Info

Publication number
PL435706A1
PL435706A1 PL435706A PL43570620A PL435706A1 PL 435706 A1 PL435706 A1 PL 435706A1 PL 435706 A PL435706 A PL 435706A PL 43570620 A PL43570620 A PL 43570620A PL 435706 A1 PL435706 A1 PL 435706A1
Authority
PL
Poland
Prior art keywords
permethrin
infestations
external treatment
demodex spp
demodex
Prior art date
Application number
PL435706A
Other languages
English (en)
Inventor
Witold TARKOWSKI
Original Assignee
Tg Pharma Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tg Pharma Spółka Z Ograniczoną Odpowiedzialnością filed Critical Tg Pharma Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL435706A priority Critical patent/PL435706A1/pl
Priority to JP2023547930A priority patent/JP2023549437A/ja
Priority to KR1020237013466A priority patent/KR20230088727A/ko
Priority to EP21819571.7A priority patent/EP4228622A1/en
Priority to US18/248,949 priority patent/US20230381129A1/en
Priority to AU2021360308A priority patent/AU2021360308A1/en
Priority to PCT/IB2021/059492 priority patent/WO2022079675A1/en
Priority to CA3195625A priority patent/CA3195625A1/en
Publication of PL435706A1 publication Critical patent/PL435706A1/pl
Priority to CL2023001086A priority patent/CL2023001086A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

Przedmiotem wynalazku jest permetryna do zastosowania w leczeniu zewnętrznym infestacji Demodex spp., w szczególności w okolicy oczu, u ludzi przy czym permetryna stosowana jest w ilości w zakresie od 5 mg/ml do 45 mg/ml, korzystnie w ilości 7,5 mg/ml.
PL435706A 2020-10-16 2020-10-16 Permetryna do zastosowania w leczeniu zewnętrznym infestacji Demodex spp. PL435706A1 (pl)

Priority Applications (9)

Application Number Priority Date Filing Date Title
PL435706A PL435706A1 (pl) 2020-10-16 2020-10-16 Permetryna do zastosowania w leczeniu zewnętrznym infestacji Demodex spp.
JP2023547930A JP2023549437A (ja) 2020-10-16 2021-10-15 ニキビダニ属の感染の治療に使用するペルメトリン
KR1020237013466A KR20230088727A (ko) 2020-10-16 2021-10-15 데모덱스 종 감염의 치료에 사용하기 위한 퍼메트린
EP21819571.7A EP4228622A1 (en) 2020-10-16 2021-10-15 Permetrin for use in the treatment of demodex spp infestation
US18/248,949 US20230381129A1 (en) 2020-10-16 2021-10-15 Permetrin for use in the treatment of demodex spp infestation
AU2021360308A AU2021360308A1 (en) 2020-10-16 2021-10-15 Permetrin for use in the treatment of demodex spp infestation
PCT/IB2021/059492 WO2022079675A1 (en) 2020-10-16 2021-10-15 Permetrin for use in the treatment of demodex spp infestation
CA3195625A CA3195625A1 (en) 2020-10-16 2021-10-15 Permetrin for use in the treatment of demodex spp infestation
CL2023001086A CL2023001086A1 (es) 2020-10-16 2023-04-14 Permetrina para uso en el tratamiento de la infestación por demodex spp.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL435706A PL435706A1 (pl) 2020-10-16 2020-10-16 Permetryna do zastosowania w leczeniu zewnętrznym infestacji Demodex spp.

Publications (1)

Publication Number Publication Date
PL435706A1 true PL435706A1 (pl) 2022-04-19

Family

ID=78821318

Family Applications (1)

Application Number Title Priority Date Filing Date
PL435706A PL435706A1 (pl) 2020-10-16 2020-10-16 Permetryna do zastosowania w leczeniu zewnętrznym infestacji Demodex spp.

Country Status (9)

Country Link
US (1) US20230381129A1 (pl)
EP (1) EP4228622A1 (pl)
JP (1) JP2023549437A (pl)
KR (1) KR20230088727A (pl)
AU (1) AU2021360308A1 (pl)
CA (1) CA3195625A1 (pl)
CL (1) CL2023001086A1 (pl)
PL (1) PL435706A1 (pl)
WO (1) WO2022079675A1 (pl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10117676A1 (de) * 2001-04-09 2002-10-10 Bayer Ag Dermal applizierbare flüssige Formulierungen zur Bekämpfung von parasitierenden Insekten an Tieren
JP7569781B2 (ja) * 2018-07-27 2024-10-18 アペルタ バイオサイエンシズ，エルエルシー デモデックスにより誘発される眼の異常および顔面の異常を治療するためのスピノシン配合
WO2020201440A1 (en) * 2019-04-03 2020-10-08 Virbac Low dose fluralaner compositions for protection against parasitic invertebrate pest

Also Published As

Publication number Publication date
CA3195625A1 (en) 2022-04-21
KR20230088727A (ko) 2023-06-20
AU2021360308A9 (en) 2024-08-08
AU2021360308A1 (en) 2023-05-25
WO2022079675A1 (en) 2022-04-21
CL2023001086A1 (es) 2023-12-15
JP2023549437A (ja) 2023-11-24
US20230381129A1 (en) 2023-11-30
EP4228622A1 (en) 2023-08-23

Similar Documents

Publication Publication Date Title
JOP20230272A1 (ar) مركبات تثبيط rip1 وطرق لتحضير واستخدامها
WO2020106647A3 (en) Combination therapy including a krasg12c inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
CL2019003892A1 (es) Nuevos derivados de azaquinolina.
MX382665B (es) 1,2,4-triazolonas 2,4,5-trisustituidas.
PH12022553530A1 (en) 1'-cyano nucleoside analogs and uses thereof
MX389697B (es) Nuevos derivados de pirazolopirimidina.
MX2021004708A (es) Metodos y composiciones para tratamiento de presbicia, midriasis y otros trastornos oculares.
CL2020002891A1 (es) Nuevos derivados de quinolina
CO2020001244A2 (es) Derivados de quinolina para tratar infecciones con helmintos
CL2019003078A1 (es) Nuevos derivados de pirazol bicíclicos.
EA200401494A1 (ru) Бактерицидные пиримидины или триазины для профилактики передачи вич половым путём
UA100116C2 (ru) Профилактика или лечение воспалительного заболевания
UY37832A (es) Dihidrooxadiazinonas
MX2023002671A (es) Formulaciones agradables.
MX2025006782A (es) Degradadores de la cinasa 4 asociada al receptor de interleucina-1 (irak4) y usos de los mismos
MX2022011697A (es) Inhibidores de ciclofilina y usos de los mismos.
UA89315C2 (en) Butylbenzene phthalein intravenous emulsion
WO2025024305A3 (en) Irak4 degraders and uses thereof
MX2024003015A (es) Nuevos derivados de quinolina.
MX2019014321A (es) Compuestos biciclicos 5,6-fusionados y composiciones para el tratamiento de enfermedades parasitarias.
PL435706A1 (pl) Permetryna do zastosowania w leczeniu zewnętrznym infestacji Demodex spp.
GEAP202516217A (en) Compounds and compositions as sppl2a inhibitors
EA201992817A1 (ru) Синергетические композиции, содержащие (r)-димирацетам (1) и (s)-димирацетам (2) в нерацемическом соотношении
PL435707A1 (pl) Fluralaner do zastosowania w leczeniu zewnętrznym infestacji Demodex spp.
MX2021012146A (es) Formulacion de tableta vaginal.